ARKAY News and Press, Arkema ADR From 10/03/25

2025-10-03 16:15:03 ET Citigroup analyst issues BUY recommendation for ARKAY on October 3, 2025 06:56PM ET. The previous analyst recommendation was Buy. ARKAY was trading at $64.71 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current a...

2025-08-13 23:45:00 ET We return to Arkema (ARKAF) (ARKAY) after nearly two years , having shifted our rating focus from integrated chemical producers to their specialty counterparts ( APD, Air Liquide, and Linde ). Given Arkema's lower EU exposure and strong balance she...

2025-08-04 02:20:00 ET After suffering a precipitous tariff-induced decline in early April, President Trump quickly announced a pause in their implementation, and global equity markets recovered aggressively to finish the 2nd quarter with a double-digit return. ...

2025-08-01 08:35:42 ET Arkema S.A. (ARKAF) Q2 2025 Earnings Conference Call July 31, 2025 05:00 AM ET Company Participants Marie-José Donsion - Chief Financial Officer Thierry Le Henaff - Chairman & CEO Conference Call Participants Aron Ceccarell...

Arkema ADR (ARKAY) is expected to report for Q2 2025

2025-07-09 04:10:42 ET Arkema ( OTCPK:ARKAF ) has announces that it is investing around $20 million to construct a new Rilsan® Clear transparent polyamide unit at its Singapore platform.... Read the full article on Seeking Alpha For further details see: Ark...

2025-05-10 10:04:04 ET Arkema S.A. (ARKAF) Q1 2025 Results Conference Call May 7, 2025 05:00 AM ET Company Participants Thierry Le Hénaff - Chairman and CEO Marie-José Donsion - CFO Conference Call Participants Martin Roediger - Kepler Cheuvreux...

Cyclerion Therapeutics Inc. (CYCN) is expected to report for Q1 2025 Standard BioTools Inc. (LAB) is expected to report $-0.06 for Q1 2025 Christian Dior SE ADR (CHDRY) is expected to report for Q1 2025 CF Bankshares Inc. (CFBK) is expected to report for Q1 2025 Jack Henry & A...

2025-04-24 08:15:07 ET Bernstein analyst issues UNDERPERFORM recommendation for ARKAY on April 24, 2025 09:11AM ET. ARKAY was trading at $71.45 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst recommendations are : 1 - Buy, 1 -...

2025-04-18 08:30:00 ET Summary Arkema's 2024 performance was solid with a net profit of 354M EUR and a robust free cash flow of 680M EUR, despite slight revenue growth. The company's balance sheet is strong with a net debt of 2.16B EUR, representing just 1.5 times the lease-adjust...